Edgestream Partners’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.7M	Buy	+19,678	New	+$2.7M	0.08%	459
2025 Q1	–	Sell	-23,810	Closed	-$3.73M	–	943
2024 Q4	$3.73M	Sell	23,810 -8,447	-26%	-$1.32M	0.16%	242
2024 Q3	$5.87M	Buy	+32,257	New	+$5.87M	0.26%	100